Overview

The Optimal Duration of Preoperative Anti-tuberculosis Treatment of Spinal Tuberculosis

Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the better preoperative anti-tuberculosis treatment period of patients with spinal tuberculosis.
Phase:
Phase 4
Details
Lead Sponsor:
Beijing Chest Hospital
Collaborator:
Beijing Municipal Science & Technology Commission
Treatments:
Antitubercular Agents
Ethambutol
Isoniazid
Pyrazinamide
Rifampin